Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Annual or biannual moxidectin versus ivermectin for onchocerciasis
PACTR202004639229710Phase 3Unknown
- Sponsor
- Medicines Development for Global Health
- Start
- Feb 2021
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of moxidectin and ivermectin in onchocerciasis (4 arms), sponsored by Medicines Development for Global Health. Status: unknown.
02
Drugs
moxidectinivermectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on PACTR202004639229710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202004639229710.